In this episode of Medsider Radio, we sat down with medtech veteran Joe DeVivo, President and CEO of Butterfly Network. Butterfly iQ3 is the startup's latest chip-powered, hand-held ultrasound device with superior image quality and ultrafast scan times. 
 
Joe is a proven executive with 35 years of business leadership experience, including 22 years in the medical device industry spanning small start-up companies to multi-billion-dollar organizations. He has acquired and fully integrated eight companies, engineered four business turnarounds, and delivered five company exits. 

In this interview, Joe shares insights on why a lean start in commercialization is better than a high-burn, high-risk approach, the difference between your company being sold and being purchased, and best practices for managing M&A transactions. 

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume V. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Joe DeVivo.